Citigroup
LVGO

Citigroup’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Citigroup’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-263,871
Closed -$37M – 7787
2020
Q3 		$37M Buy
263,871
+249,137
+1,691% +$30.4M 0.02% 591
2020
Q2 		$1.11M Sell
14,734
-199
-1% -$10.4K ﹤0.01% 3455
2020
Q1 		$426K Buy
14,933
+11,975
+405% +$310K ﹤0.01% 4019
2019
Q4 		$74K Buy
2,958
+2,288
+341% +$54.7K ﹤0.01% 6017
2019
Q3 		$11K Buy
+670
New +$20.3K ﹤0.01% 7046

Citigroup's LVGO Position: Q4 2020 in Review

Citigroup sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 263,871 shares — an estimated $37M sold.

Citigroup first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $37M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Citigroup reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Citigroup sold 263,871 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $37M.
  • Citigroup first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Citigroup's Livongo Health, Inc. Common Stock position peaked at $37M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.